10.72
-0.44 (-3.94%)
| Previous Close | 11.16 |
| Open | 11.25 |
| Volume | 408,726 |
| Avg. Volume (3M) | 785,518 |
| Market Cap | 321,450,112 |
| Price / Sales | 8.27 |
| Price / Book | 18.59 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2026 |
| Profit Margin | -64.51% |
| Operating Margin (TTM) | -72.63% |
| Diluted EPS (TTM) | -0.760 |
| Quarterly Revenue Growth (YOY) | 11.10% |
| Total Debt/Equity (MRQ) | 17.20% |
| Current Ratio (MRQ) | 3.53 |
| Operating Cash Flow (TTM) | -11.28 M |
| Levered Free Cash Flow (TTM) | -2.92 M |
| Return on Assets (TTM) | -32.39% |
| Return on Equity (TTM) | -76.21% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | ClearPoint Neuro Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | -1.5 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 0.5 |
| Average | -0.50 |
|
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 8.22% |
| % Held by Institutions | 34.64% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Firstwave Capital Management Llc | 31 Dec 2025 | 363,409 |
| 52 Weeks Range | ||
| Median | 18.00 (67.91%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| B. Riley Securities | 05 Mar 2026 | 18.00 (67.91%) | Buy | 9.25 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| FALLON LYNNETTE C | - | 11.20 | -5,091 | -57,019 |
| FLETCHER R JOHN | - | - | 0 | 0 |
| GIRIN PASCAL E R | - | - | 0 | 0 |
| JOHNSON B KRISTINE | - | - | 0 | 0 |
| KLEIN MATTHEW B. | - | - | 0 | 0 |
| LIAU LINDA M. | - | - | 0 | 0 |
| RICHARDS TIMOTHY T. | - | - | 0 | 0 |
| Aggregate Net Quantity | -5,091 | |||
| Aggregate Net Value ($) | -57,019 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 11.20 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| FALLON LYNNETTE C | Director | 20 May 2026 | Automatic sell (-) | 5,091 | 11.20 | 57,019 |
| LIAU LINDA M. | Director | 19 May 2026 | Option execute | 12,417 | - | - |
| GIRIN PASCAL E R | Director | 19 May 2026 | Option execute | 12,417 | - | - |
| RICHARDS TIMOTHY T. | Director | 19 May 2026 | Option execute | 12,417 | - | - |
| JOHNSON B KRISTINE | Director | 19 May 2026 | Option execute | 12,417 | - | - |
| FLETCHER R JOHN | Director | 19 May 2026 | Option execute | 12,417 | - | - |
| KLEIN MATTHEW B. | Director | 19 May 2026 | Option execute | 12,417 | - | - |
| FALLON LYNNETTE C | Director | 19 May 2026 | Option execute | 12,417 | - | - |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |